from TheAge
"
10:20am: The main loser among the top 200 this morning is CSL, which is down about 5 per cent after an Alzheimer's therapy by competitor Baxter failed in late stage trial.
This is seen as a blow for CSL as both the Australian company and Baxter stood to benefit from the potential use of immunoglobulin treatments in Alzheimer's patients.
"
Read more: http://www.theage.com.au/business/markets-live/markets-live-strong-start-for-stocks-20130508-2j6lc.html#ixzz2SekCqnAq
price drop, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$294.88 |
Change
1.180(0.40%) |
Mkt cap ! $142.5B | |||
| Open | High | Low | Value | Volume |
| $294.99 | $296.49 | $293.82 | $249.0M | 844.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 347 | $294.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $294.89 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |